Pfizer Inc is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents reviewed by Reuters that describe how the trial is being run.
https://www.reuters.com/article/health-coronavirus-usa-vaccines-idUSKBN26907S